Edgewise Therapeutics, Inc. (16)
Browse by Contract Category
Contracts
-
Form of Underwriting Agreement
(Filed With SEC on March 24, 2021)
-
2021 Equity Incentive Plan and forms of agreements thereunder, to be in effect upon the completion of this offering
(Filed With SEC on March 22, 2021)
-
Form of Indemnification Agreement between the Registrant and each of its directors and executive officers
(Filed With SEC on March 5, 2021)
-
Offer Letter between the Registrant and Kevin Koch, Ph.D
(Filed With SEC on March 5, 2021)
-
Lease between the Registrant and Regents of the University of Colorado, dated July 21, 2020
(Filed With SEC on March 5, 2021)
-
Specimen common stock certificate of the Registrant
(Filed With SEC on March 22, 2021)
-
2021 Employee Stock Purchase Plan and forms of agreements thereunder, to be in effect upon the completion of this offering
(Filed With SEC on March 22, 2021)
-
Amended and Restated Investors Rights Agreement by and among the Registrant and certain of its stockholders, dated December 3, 2020
(Filed With SEC on March 5, 2021)
-
2017 Equity Incentive Plan, as amended, and forms of agreement thereunder
(Filed With SEC on March 5, 2021)
-
Offer Letter between the Registrant and Alan Russell, Ph.D
(Filed With SEC on March 5, 2021)
-
Offer Letter between the Registrant and R. Michael Carruthers
(Filed With SEC on March 5, 2021)
-
Offer Letter between the Registrant and Behrad Derakhshan, Ph.D
(Filed With SEC on March 5, 2021)
-
Offer Letter between the Registrant and John Moore
(Filed With SEC on March 5, 2021)
-
Executive Incentive Compensation Plan
(Filed With SEC on March 5, 2021)
-
Executive Change in Control and Severance Plan
(Filed With SEC on March 5, 2021)
-
Outside Director Compensation Policy
(Filed With SEC on March 5, 2021)